Differentiation therapy

• 1 August 2003
• journal article
• Published by Elsevier in Current Opinion in Pharmacology
• Vol. 3  (4) , 338-343
• https://doi.org/10.1016/s1471-4892(03)00081-x

Abstract

Keywords

• AML
• ACUTE MYELOGENOUS LEUKEMIA
• APL
• ACUTE PROMYELOCYTIC LEUKEMIA
• ATRA
• ALL-TRANS RETINOIC ACID
• AZAC
• AZACYTIDINE
• CML
• CHRONIC MYELOGENOUS LEUKEMIA
• EBP
• ENHANCER BINDING PROTEIN
• HDAC
• HISTONE DEACETYLASE
• MDS
• MYELODYSPLASTIC SYNDROME
• MTD
• MAXIMUM TOLERATED DOSE
• PHENYLBUTYRATE
• PPAR